Lead and Peripheral Neuropathy, Computerized Dementia Screening,Buccal Fentanyl, FDA Electronic Surveillance for Side Effects
Exposure to even low levels of lead may be associated with increased risk for peripheral neuropathy. A new computerized test for dementia may be useful for office screening. The FDA recommended against approving the buccal formulation of fentanyl for pain other than that associated with cancer. The FDA has also developed a new electronic surveillance system to identify adverse drug reactions.
Right click on the icon with the format of your choice (MP3 or Windows Media) and select "Save Target As..." or "Save Link As..." to download the file to your MP3 player or computer. Click on the grey arrow below to listen on your computer.
File Size: 14.17 MB Playtime: 15:28
Subscribe directly using your preferred podcasting tool:
Or, copy and paste this URL into a podcasting tool:
